|
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017[Erratum:Lancet. 2018 Nov;392(10159):1923-1994.] |
Lancet. 2019 Jun 22-28;393(10190):Article number e44. |
 |
| 2017-09 |
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016 |
Lancet. 2017 Sep;390(10100):1345-1422. |
|
| 2015-08 |
Global, regional, and national consumption of sugar-sweetened beverages, fruit juices, and milk: A systematic assessment of beverage intake in 187 countries |
PLoS ONE. 2015 Aug;10(8):Article number e0124845. |
|
| 2017-09 |
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016 |
Lancet. 2017 Sep;390(10100):1211-1259. |
|
| 2018-11 |
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 |
Lancet. 2018 Nov;392(10159):1789-1858. |
|
| 2016-10-08 |
Global, regional, and national levels of maternal mortality, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015 |
Lancet. 2016 Oct 8;388(10053):1775-1812. |
|
| 2017-01 |
Global, regional, and national levels of maternal mortality, 1990–2015: A systematic analysis for the global burden of disease study 2015 |
Obstetrical and Gynecological Survey. 2017 Jan;72(1):11-13. |
|
| 2017-01-07 |
Global, regional, and national levels of maternal mortality, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015[Erratum:Lancet. 2016 Oct 8;388(10053):1775-1812.] |
Lancet. 2017 Jan 07;389(10064):Article number e1. |
|
| 2021-10 |
Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: A systematic analysis for the Global Burden of Disease Study 2019 |
Lancet. 2021 Oct;398(10311):1593-1618. |
|
| 2016-10-08 |
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015 |
Lancet. 2016 Oct 8;388(10053):1725-1774. |
|
|
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015[Erratum:Lancet. 2016 Oct 8;388(10053):1725-1774.] |
Lancet. 2017 Jan 7-13;389(10064):Article number e1. |
|
| 2006-11-10 |
Globalization and health security: The EU and Taiwan's participation in the WHO |
The EU-Asia Bilateral Academic Dialogue. 2006 Nov. 10-19. |
|
| 2020-07-22 |
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: Phase II randomized, placebo-controlled study |
Journal for Immunotherapy of Cancer. 2020 Jul 22;8(2):Article number e000342. |
|
| 2017-04 |
Glossogyne tenuifolia (Hsiang-ju) extract suppresses T cell activation by inhibiting activation of c-Jun N-terminal kinase |
Chinese Medicine. 2017 Apr. 11;12:Article number 9. |
|
| 2024-06 |
Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes |
Clinical Gastroenterology and Hepatology. 2024 Jun;22(6):1255-1264.e18. |
|
| 2024-08-08 |
Glucagon-like peptide-1 receptor agonists and risk of sight-threatening retinopathy in Taiwanese population: A propensity based cohort study |
Diabetes and Metabolic Syndrome. 2024 Aug 08;18(8):Article number 103099. |
|
|
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD |
Thorax. 2024 Oct16;79:1017-1023. |
|
| 2006-02 |
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kappa B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa |
Journal of Endocrinology. 2006 Feb;188(2):311-319. |
|
| 2016-12 |
Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer |
Oncotarget. 2016 Dec;7(52):85917-85928. |
|
| 2015-01-08 |
Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B |
Nature Communications. 2015 Jan 8;6:Article number 5917. |
|
| 2015-12 |
Glucosamine modulates T cell differentiation through down-regulating N-linked glycosylation of CD25 |
Journal of Biological Chemistry. 2015 Dec;290(49):29329-29344. |
|
| 2016-11 |
Glucose-dependent insulinotropic polypeptide ameliorates mild traumatic brain Injury-Induced cognitive and sensorimotor deficits and neuroinflammation in rats |
Journal of Neurotrauma. 2016 Nov;33(22): 2044-2054. |
|
| 2017-04-09 |
Glucose-sensitive self-healing hydrogel as sacrificial materials to fabricate vascularized constructs |
Biomaterials. 2017 Apr 09;133:20-28. |
|
| 2006-02 |
Glucosyltransferases of viridans group streptococci modulate interleukin-6 and adhesion molecule expression in endothelial cells and augment monocytic cell adherence |
Infection and Immunity. 2006 Feb;74(2):1273-1283. |
|
| 2005-06 |
Glucosyltransferases of viridans streptococci are modulins of interleukin-6 induction in infective endocarditis |
Infection and Immunity. 2005 Jun;73(6):3261-3270. |
|
